GPT and viral hepatitis: In another study, 29 patients with viral hepatitis treated with silymarin and 28 patients received placebo; serum bilirubin, AST and ALT levels significantly reduced in the treatment group but in another study with 151 patients with viral hepatitis this drug could not improve their clinical condition [14].